1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow MAP2K1 Gene Mutation: new trials by email Literature Review of MAP2K1 Gene Mutation trials Research Report on MAP2K1 Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer Laboratory Biomarker Analysis, Panitumumab, Trametinib - EGFR NP_005219.2:p.S492R, KRAS Gene Mutation | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 59 | 2017-12-29 | 2026-07-16 |
Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
Panitumumab (1) · trametinib (1)
M.D. Anderson Cancer Center (1)
United States (1)